The challenge is volume; with a small market, there isn't much motivation to struggle to stay in business selling at low margins. Also, since these may be considered accessibility devices but not medical devices, insurance May not cover a lot of things that ought to be considered essential.
The profit motive is everywhere in the medical sector, and that is a bad thing. Even if you believe in free markets, it's not easy to get the best care.
To stay cose to the eye as a subject, look at vitreomacular adhesion. Roughly two possible treatments:
- costly and complicated eye surgery
- substantially simpler ocriplasmin [0] injections
In many cases where ocriplasmin looks like it could be the perfect solution, it isn't even considered. Could that have something to do with the surgeon's incentives alignment?
The challenge is volume; with a small market, there isn't much motivation to struggle to stay in business selling at low margins. Also, since these may be considered accessibility devices but not medical devices, insurance May not cover a lot of things that ought to be considered essential.